Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. Its Immune-stimulating Antibody Conjugates (ISAC) eliminate tumors following systemic administration in preclinical studies and results in the development of immunological memory. The company also develops Myeloid Modulator Platform that reawakens myeloid cells to attack tumor cells.
Type | Public | |
Founded | 2015 | |
HQ | Redwood City, CA, US | Map |
Website | boltbio.com |
USD | |
---|---|
Net income (Q1, 2021) | (24.5m) |
EBIT (Q1, 2021) | (18.4m) |
Market capitalization (6-May-2022) | 52.6m |
Closing stock price (6-May-2022) | 1.4 |
Cash (31-Mar-2021) | 95.5m |
EV | (32.2m) |
USD | FY, 2018 |
---|---|
Financial Leverage | -1 x |
Bolt Biotherapeutics has 239 Twitter Followers. The number of followers has increased 1.3% month over month and increased 4.5% quarter over quarter
97
Tweets
155
Following
239
Followers
3
Tweets last 30 days
5.7
Avg. likes per Tweet
100%
Tweets with engagement
When was Bolt Biotherapeutics founded?
Bolt Biotherapeutics was founded in 2015.
Who are Bolt Biotherapeutics key executives?
Bolt Biotherapeutics's key executives are Randy Schatzman, Grant Yonehiro and Priti Hegde.
How many employees does Bolt Biotherapeutics have?
Bolt Biotherapeutics has 63 employees.
What is Bolt Biotherapeutics revenue?
Latest Bolt Biotherapeutics annual revenue is $215 k.
What is Bolt Biotherapeutics revenue per employee?
Latest Bolt Biotherapeutics revenue per employee is $3.4 k.
Who are Bolt Biotherapeutics competitors?
Competitors of Bolt Biotherapeutics include Forbius, OncoQR ML and Nkarta Therapeutics.
Where is Bolt Biotherapeutics headquarters?
Bolt Biotherapeutics headquarters is located at 900 Chesapeake Dr, Redwood City.
Where are Bolt Biotherapeutics offices?
Bolt Biotherapeutics has an office in Redwood City.
How many offices does Bolt Biotherapeutics have?
Bolt Biotherapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies